Strategic Advisory Board

Annemarie Schols

Prof. Dr. Annemarie Schols

Profile

Prof. Dr. Annemie Schols has been recently appointed as the new dean of the Faculty of Health, Medicine and Life Sciences (FHML) as of 1 June 2020. As Professor of Nutrition and Metabolism in Chronic Diseases, Prof. Dr. Schols has a long career within FHML, also as a researcher and as director of the School of Nutrition and Translational Research in Metabolism (NUTRIM). Under her leadership, NUTRIM has grown into a worldwide Center of Excellence for research in the fields of obesity, diabetes, chronic obstructive pulmonary disease (COPD) and cancer cachexia.

In 2015, Schols was awarded the prestigious ERS COPD, being distinguished not only for her research work but also for her efforts to bring together all kinds of disciplines in the COPD research field and to build bridges.

Maarten Merkx

Prof. Dr. Maarten Merkx

Profile

Prof. Dr. Maarten Merkx became the dean of the TU/e department of Biomedical Engineering in November 2019, where he studied physical organic chemistry and biochemistry at the Radboud University Nijmegen (1995, cum laude). He did his PhD with Prof. Averill (1999, University of Amsterdam) working on purple acid phosphatases, and was an HSFP post-doctoral fellow with Prof. Lippard (MIT, 1999-2001). Currently he is a full professor in protein engineering at the Eindhoven University of Technology, a core member of the Institute for Complex Molecular Systems (ICMS) and dean of the department of Biomedical Engineering. He obtained young investigator grants from NWO (VIDI 2006), an ERC Consolidator grant in 2011, and an ERC Proof of Concept grant in 2014 and 2017.

As the only Dutch scientist, he was invited in 2015 to speak at the World Economic forum in a session on the future of synthetic biology. In 2017, he reached the media with his expertise on DNA computing, amongst others an article on wired.com, and in 2019, he received an NWO Take Off grant to map the commercial possibilities of his glow-in-the-dark paper-based assays for point-of-care diagnostics. Furthermore, he was awarded multiple times as best teacher in the master’s program, and received the award for the best TU/e teacher at the master level in 2012. In November 2019, he became the dean of the TU/e department of Biomedical Engineering.

Arno W. Hoes

Prof. Dr. Arno W. Hoes

Profile

Arno W. Hoes studied Medicine at the Radboud University in Nijmegen and obtained his PhD degree at Erasmus University Rotterdam on a thesis on sudden cardiac death as a side effect of diuretics in hypertension. From 2010 to 2019, he was the Chair/Medical Manager of the Julius Center for Health Sciences and Primary Care of the UMC Utrecht. June 2019 he was appointed as vice-chair of the executive board of University Medical Center Utrecht and as dean of the medical faculty of Utrecht University / UMC Utrecht.

His main research topics include the prevention of cardiovascular disease and the early diagnosis and management of cardiovascular disease, with an emphasis on heart failure. His teaching activities include courses on clinical epidemiology, diagnostic research, clinical trials, case-control studies and cardiovascular disease and prevention. He is also member of several Dutch and European health councils, boards and associations.

Wouter Dhert

Prof. Dr. W.J.A. Dhert

Profile

Since December 2014, Wouter Dhert is the dean of the Faculty of Veterinary Medicine and full professor of translational musculoskeletal research at Utrecht University. From 2008 until 2014 he was full professor at the Dept. of Orthoapedics at the University Medical Center Utrecht and part-time professor at the Faculty of Veterinary Medicine. He studied Medicine at Leiden University after which he obtained a PhD at the Leiden Biomaterials Research Group in 1993. Until 2014 he was chair of the UMC Utrecht research program ‘Regenerative Medicine & Stem Cells’ and member of the management team (vice-chair - reseach and education) of the division of Surgical Specialties.

He is experienced in developing and leading teaching programs (e.g. PhD program ‘Regenerative Medicine’ as well as of the Master Program ‘Regenerative Medicine & Technology’ (in collaboration with Eindhoven University of Technology) of the Utrecht University Graduate School of Life Sciences). He serves at several international committees/boards related to regenerative medicine and/or musculoskeletal research. In 2000 he was acknowledged as international Fellow in Biomaterials Science and Engineering (FBSE), in 2001 he received the Dutch ‘Anna-award’ for establishing a ‘most-promising post-doctoral research line’. In 2008, he was President of the World Biomaterials Congress in Amsterdam.

Pancras Hogendoorn

Prof. Dr. Pancras Hogendoorn

Profile

Pancras C.W. Hogendoorn is a professor of pathology, vice-chair of the Board of Directors, and dean of the Leiden University Medical Center (LUMC). He is also a guest professor at Oxford University and the Free University of Brussels (FUB) and chairman of the Netherlands Committee for Bone Tumours, a member of the Supervisory Board of the care organization Pieter van Foreest, and the Royal Academy of Arts/Conservatoire.

Pancras C.W. Hogendoorn absolved Medical School and his doctoral research at Leiden University. Subsequently, Prof. Hogendoorn further specialized in oncologic pathology at the Netherlands Cancer Institute (NKI) in Amsterdam and the Memorial Sloan Kettering Cancer Center in New York. For more than 25 years, Prof. Hogendoorn has researched molecular pathogenesis and diagnostics of bone and soft-tissue tumors. He has over 400 scientific publications and various influential reviews and 28 chapters of books to his name. Currently, he is chairman of the Netherlands Committee for Bone Tumours, a member of the knowledge coalition for the Dutch National Research Agenda, Chief Scientific Officer of the top team Lifescience and Health, member of Education and Training (O&O) at the Netherlands Federation of University Medical Centres (NFU), and chairman of the League of European Research Universities (LERU) Policy Group in Biomedicine.

Tom Oostrom (Stab)

Tom Oostrom

Profile

Tom Oostrom (1964) has been Managing Director of the Dutch Kidney Foundation since 2010. He started as head of the policy section in 2005. With the motto "Life comes first" the Kidney Foundation gives everything to make sure kidney patients survive ánd their quality of life improves. Tom Oostrom learned from practice: he started out as a nurse. His drive is to make a real difference for kidney patients, to help make their lives livable.

Since 2012 Oostrom has been the chair of the cooperating healthcare funds (Samenwerkende Gezondheidsfondsen) in which 21 large funds are united. He is also a member of the Regiegroep Life Sciences & Health and is committed to promote active involvement of healthcare funds in the topsector policy. Oostrom is also vice-president of the NPHF, Federation for Health.In Leiden Oostrom studied to become a nurse (1986). He studied Policy & Management in Healthcare at Erasmus University Rotterdam (1991).

Floris Italianer

Floris Italianer

Profile

Floris Italianer has been director of the Dutch Heart Foundation since 1 May 2013. Together with top scientists and many partners, the Dutch Heart Foundation is looking for solutions that contribute to a healthy heart. Italianer studied economics at the University of Groningen and received his master's degree in Business Administration from the Interfaculty of Business Administration.

He advised, among others, healthcare institutions and medical specialists on new activities, financing, and growth. In addition to his position, Floris Italianer also fulfills several roles as a board member of the Health Funds for Smoke-Free (GvRV) and the Lottery Actions Public Health Foundation; president of the European Heart Network, member of the advisory board of the Durrer Center and the Strategic Health Area TU Eindhoven and member of Sensus' Committee of Recommendation.

Etelka Ubbens

Etelka Ubbens

Profile

Etelka Ubbens is the general manager of the Diabetes Fund as of July 15, 2020. Etelka previously worked for Philips in many different marketing and management positions, including in the areas of personal health and digital transformation. She has led several global businesses and has extensive experience in innovation, strategy, and partnerships. In addition, Etelka held various board positions like Global Head of Philips Direct Online and Senior Vice President.

When the Diabetes Fund came into her path, Etelka Ubbens was immediately enthusiastic: 'I am happy to lead the Diabetes Fund. In the Netherlands, 1.2 million people have diabetes, a huge number, and still growing. I would like to make every effort to prevent and cure this disease, which has many consequences for the people who suffer from it and their environment. The Diabetes Fund has already achieved a lot with scientific research and information, in close collaboration with other parties. I look forward to further contributing to this. '

Floor Dijkgraaf

Floor Dijkgraaf

Profile

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas porttitor congue massa. Fusce posuere, magna sed pulvinar ultricies, purus lectus malesuada libero, sit amet commodo magna eros quis urna.

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas porttitor congue massa. Fusce posuere, magna sed pulvinar ultricies, purus lectus malesuada libero, sit amet commodo magna eros quis urna. '

Jan Willem Förch

Jan Willem Förch

Profile

As of 1 January 2020, Jan-Willem Förch is the general director of ReumaNederland. Förch will lead the charity organization for over 2 million people with rheumatism. For the past six years, Förch was responsible for fundraising at the Dutch Cancer Society and was previously director of marketing and communication agencies.

“ReumaNederland is both a health fund and a modern patient organization, which is a strongly chosen course in which I have great confidence. In addition to fundraising, I look forward to expanding patient advocacy. ”

Marianne Verhaar FC

Prof. Dr. Marianne C. Verhaar

Profile

Marianne C. Verhaar is a Nephrologist and Professor of Experimental Nephrology at the University Medical Center Utrecht, the Netherlands. She is chair of the Department of Nephrology and Hypertension and heads a research group in Experimental Nephrology. In 1992 she started her Ph.D. project at the Department of Nephrology and Hypertension in Utrecht. She received her Ph.D. degree in 1999 and from 2000 to 2008 she worked as a staff member of Vascular Medicine and since 2003, also as head of the research laboratory 'Regenerative Vascular Medicine / Renal and Vascular Biology' in UMC Utrecht. In 2015 she has been appointed chair of the UMC Utrecht Research Program Regenerative Medicine & Stem Cells. Her research focuses on renal and vascular regeneration and involves translational studies from basic cell studies to clinical trials. Marianne Verhaar received several prestigious grants from the Netherlands Organisation for Scientific Research, the Dutch Heart Foundation, and the Dutch Kidney Foundation.

Prof Dr. Ton A.J. Rabelink

Prof Dr. Ton A.J. Rabelink (Moonshot Leader)

Profile

Ton J Rabelink, MD, PhD, is professor of Medicine at the Leiden University Medical Center. He received his MD PhD degree from Utrecht University. After completing his residency and fellowships in internal medicine and nephrology he joined faculty of Utrecht Medical School in 1993. He subsequently became chairman of medicine in the University Hospital Utrecht from 1999 to 2004. In 2004 he moved to Leiden University Medical Center and became head of the department of Nephrology and Transplantation and in 2010 chairman of Medicine again. His main research interest has been in the area of vascular biology and its implications for renal function, and in regenerative therapies for kidney disease and diabetes. He coordinates the European-Australian consortium on stem cell based therapy for kidney disease (STELLAR) and is leading the Dutch National Science Agenda for regenerative medicine.

Prof. Dr. Carlijn V.C. Bouten

Prof. Dr. Carlijn V.C. Bouten

Profile

Carlijn Bouten is professor of Cell-Matrix Interactions at the department Biomedical Engineering of the Eindhoven University of Technology (TU/e). She was trained in functional anatomy and biomechanics, as well as exercise physiology, at the department of Human Movement Sciences, VU Amsterdam, and obtained her PhD degree in 1995 from the TU/e. She performed postdoctoral research at the Université Laval (Quebec), University of London, and Eindhoven University of Technology. In 1998 she became assistant professor in Cellular Biomechanics in the department of Mechanical Engineering, TU/e, and in 2002 she became associate professor of Tissue Engineering in the department of Biomedical Engineering, TU/e. Her research concentrates on new engineering approaches to regenerate the tissues of the cardiovascular system. A particular example is the development of a synthetic, bio-degradable heart valve prosthesis that ‘seduces’ the body to create a new, living heart valve at the site of implantation. The research is performed in close collaboration with material scientists, life scientists and clinicians, and mainly executed within public-private partnerships. She is recipient of the prestigious Aspasia (2002) and VICI (2003) career development awards of the Dutch National Science Foundation and theme-leader ‘Regenerative Medicine’ of the strategic area Health at TU/e.


  • Diabetes FondsDiabetes Fonds
  • Leids Universitair Medisch CentrumLeids Universitair Medisch Centrum
  • Provincie UtrechtProvincie Utrecht
  • RijksoverheidRijksoverheid
  • Health HollandHealth Holland
  • Maastricht UMC+Maastricht UMC+
  • Provincie LimburgProvincie Limburg
  • TU/eTU/e
  • NierstichtingNierstichting
  • Provincie Noord-BrabantProvincie Noord-Brabant
  • Universiteit LeidenUniversiteit Leiden
  • LeidenLeiden
  • Stichting DONStichting DON
  • ReumaNederlandReumaNederland
  • Maastricht UniversityMaastricht University
  • UMC UtrechtUMC Utrecht
  • Utrecht UniversityUtrecht University
  • KU LeuvenKU Leuven
  • VIBVIB
  • HartstichtingHartstichting
  • 300Microns300Microns
  • Access2boneAccess2bone
  • Chemelot InSciTeChemelot InSciTe
  • Cyto smartCyto smart
  • Dutch CardioVascular AllianceDutch CardioVascular Alliance
  • Flanders State of the ArtFlanders State of the Art
  • FUJIFILMFUJIFILM
  • GalápagosGalápagos
  • HCM MedicalHCM Medical
  • Kuros BiosciencesKuros Biosciences
  • LifeTec GroupLifeTec Group
  • MateriomicsMateriomics
  • MimetasMimetas
  • Ministerie van Economische Zaken en KlimaatMinisterie van Economische Zaken en Klimaat
  • Ministerie van Onderwijs Cultuur en WetenschapMinisterie van Onderwijs Cultuur en Wetenschap
  • Ministerie van Volksgezondheid, Welzijn en SportMinisterie van Volksgezondheid, Welzijn en Sport
  • NcardiaNcardia
  • Nestegg BiotechNestegg Biotech
  • NTrans TechnologiesNTrans Technologies
  • Ostheo PharmaOstheo Pharma
  • Provincie Zuid-HollandProvincie Zuid-Holland
  • ScinusScinus
  • Starfish InnovationsStarfish Innovations
  • StentitStentit
  • SupraPolixSupraPolix
  • veldlaserveldlaser
  • VisualsonicsVisualsonics
  • XeltisXeltis

Information for

Contact information

  • Stichting REGMED XB
  • Minderbroedersberg 4-6, 6211 LK  Maastricht
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Connect with us

Copyright © 2021 RegMed XB. All rights reserved
Realisation & design by Joomlapartner